Cargando…

Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis

Glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase is frequently inactivated by the oncogenic signalling kinases PI3K/Akt and MAPK/ERK in diverse malignancies. The present study was designed to investigate GSK-3β signalling circuits in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sophia, Josephraj, Kiran Kishore T., Kranthi, Kowshik, Jaganathan, Mishra, Rajakishore, Nagini, Siddavaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763291/
https://www.ncbi.nlm.nih.gov/pubmed/26902162
http://dx.doi.org/10.1038/srep22192
_version_ 1782417242291437568
author Sophia, Josephraj
Kiran Kishore T., Kranthi
Kowshik, Jaganathan
Mishra, Rajakishore
Nagini, Siddavaram
author_facet Sophia, Josephraj
Kiran Kishore T., Kranthi
Kowshik, Jaganathan
Mishra, Rajakishore
Nagini, Siddavaram
author_sort Sophia, Josephraj
collection PubMed
description Glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase is frequently inactivated by the oncogenic signalling kinases PI3K/Akt and MAPK/ERK in diverse malignancies. The present study was designed to investigate GSK-3β signalling circuits in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model and the therapeutic potential of the neem limonoid nimbolide. Inactivation of GSK-3β by phosphorylation at serine 9 and activation of PI3K/Akt, MAPK/ERK and β-catenin was associated with increased cell proliferation and apoptosis evasion during stepwise evolution of HBP carcinomas. Administration of nimbolide inhibited PI3K/Akt signalling with consequent activation of GSK-3β thereby inducing trafficking of β-catenin away from the nucleus and enhancing the expression of miR-126 and let-7. Molecular docking studies confirmed interaction of nimbolide with PI3K, Akt, ERK and GSK-3β. Furthermore, nimbolide attenuated cell proliferation and induced apoptosis as evidenced by increased p-cyclin D1(Thr286) and pro-apoptotic proteins. The present study has unravelled aberrant phosphorylation as a key determinant for oncogenic signalling and acquisition of cancer hallmarks in the HBP model. The study has also provided mechanistic insights into the chemotherapeutic potential of nimbolide that may be a useful addition to the armamentarium of natural compounds targeting PI3K for oral cancer treatment.
format Online
Article
Text
id pubmed-4763291
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47632912016-03-01 Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis Sophia, Josephraj Kiran Kishore T., Kranthi Kowshik, Jaganathan Mishra, Rajakishore Nagini, Siddavaram Sci Rep Article Glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase is frequently inactivated by the oncogenic signalling kinases PI3K/Akt and MAPK/ERK in diverse malignancies. The present study was designed to investigate GSK-3β signalling circuits in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model and the therapeutic potential of the neem limonoid nimbolide. Inactivation of GSK-3β by phosphorylation at serine 9 and activation of PI3K/Akt, MAPK/ERK and β-catenin was associated with increased cell proliferation and apoptosis evasion during stepwise evolution of HBP carcinomas. Administration of nimbolide inhibited PI3K/Akt signalling with consequent activation of GSK-3β thereby inducing trafficking of β-catenin away from the nucleus and enhancing the expression of miR-126 and let-7. Molecular docking studies confirmed interaction of nimbolide with PI3K, Akt, ERK and GSK-3β. Furthermore, nimbolide attenuated cell proliferation and induced apoptosis as evidenced by increased p-cyclin D1(Thr286) and pro-apoptotic proteins. The present study has unravelled aberrant phosphorylation as a key determinant for oncogenic signalling and acquisition of cancer hallmarks in the HBP model. The study has also provided mechanistic insights into the chemotherapeutic potential of nimbolide that may be a useful addition to the armamentarium of natural compounds targeting PI3K for oral cancer treatment. Nature Publishing Group 2016-02-23 /pmc/articles/PMC4763291/ /pubmed/26902162 http://dx.doi.org/10.1038/srep22192 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Sophia, Josephraj
Kiran Kishore T., Kranthi
Kowshik, Jaganathan
Mishra, Rajakishore
Nagini, Siddavaram
Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title_full Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title_fullStr Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title_full_unstemmed Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title_short Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis
title_sort nimbolide, a neem limonoid inhibits phosphatidyl inositol-3 kinase to activate glycogen synthase kinase-3β in a hamster model of oral oncogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763291/
https://www.ncbi.nlm.nih.gov/pubmed/26902162
http://dx.doi.org/10.1038/srep22192
work_keys_str_mv AT sophiajosephraj nimbolideaneemlimonoidinhibitsphosphatidylinositol3kinasetoactivateglycogensynthasekinase3binahamstermodeloforaloncogenesis
AT kirankishoretkranthi nimbolideaneemlimonoidinhibitsphosphatidylinositol3kinasetoactivateglycogensynthasekinase3binahamstermodeloforaloncogenesis
AT kowshikjaganathan nimbolideaneemlimonoidinhibitsphosphatidylinositol3kinasetoactivateglycogensynthasekinase3binahamstermodeloforaloncogenesis
AT mishrarajakishore nimbolideaneemlimonoidinhibitsphosphatidylinositol3kinasetoactivateglycogensynthasekinase3binahamstermodeloforaloncogenesis
AT naginisiddavaram nimbolideaneemlimonoidinhibitsphosphatidylinositol3kinasetoactivateglycogensynthasekinase3binahamstermodeloforaloncogenesis